Home / Knowledge Centre /

Easy as 1, 2, 3: how to select the right comparator sourcing model for your clinical trial

Comparative trials offer a host of benefits, least of all the ability to demonstrate a study drug’s enhanced efficacy and tolerability compared with the best performing commercially available alternative. Unsurprisingly, comparator drugs and co-therapies are used in an estimated two-thirds of clinical trials and are widely considered a prerequisite for formulary listing and even successful licensure.

Before comparative trials can begin to pay dividends, sponsors need to create strong comparator sourcing strategies that safeguard timely, compliant and cost-effective supply to patients. this requires sponsors to select the best-fit sourcing strategy.

Download the guide to read more.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies